#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prophylaxis against transplant rejection Primary mediastinal large B-cell lymphoma Hairy cell leukaemia recurrent Round cell liposarcoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Granulomatosis with polyangiitis Acute graft versus host disease in liver Short stature homeobox gene mutation Isodicentric chromosome 15 syndrome Uterine leiomyosarcoma Chronic kidney disease Myelofibrosis Acute lymphocytic leukaemia Heavy menstrual bleeding Ischaemic stroke More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Diagnostics Systemic mastocytosis MELAS syndrome Activated PI3 kinase delta syndrome – Basic Information Epidermolysis bullosa – Treatment Antithrombin III deficiency – Treatment Glomerulonephritis membranous – Trials in Disease Ewing’s sarcoma metastatic – Diagnostics Mitochondrial myopathy – Diagnostics Carcinoid syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Axatilimab Colestyramine Carbasalate Calcium Selexipag Roxithromycin Loperamide ADS-019 REGN7999 E2814 Phleum Pratense Pollen Extract Tyra-300-B01 Gsk3965193B Upacicalcet Sodium Hydrate AMLENETUG Heterodimeric Interleukin-15 Amivantamab Magnesium Oxybate Potassium Canrenoate Nimotuzumab Amlitelimab More therapies…

    Learn about Your Condition

    Premature rupture of membranes Neuralgia Postprandial hypoglycaemia Dry eye Congenital ureteric anomaly K-ras gene mutation Dent's disease Endometrial cancer stage IV Liver transplant rejection Burning mouth syndrome Alcohol use disorder Crigler-Najjar syndrome Richter's syndrome Cataract Polycystic ovarian syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Head injury

  • Study on Naloxegol to Prevent Constipation in Patients with Brain Injury and Opioid Use

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastrointestinal motility disorder
    • Head injury
    • Cerebral haemorrhage
    Investigated Drugs:
    • Naloxegol Oxalate
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!